PATH Insights brings you the latest updates on all things PATH—from new program announcements to featured interviews with our staff to our latest mentions in the news. Look out for a newsletter in your inbox about once a month, with the occasional special edition appearing throughout the year on more timely issues.
In this issue of PATH Insights, we take a closer look at what’s driving COVID-19 in Africa, how health workers can help optimize vaccine rollout, and Delta’s implications for diagnostic testing.
In this edition of PATH Insights, we’re looking at how to design pandemic response strategies—from producing and manufacturing COVID-19 vaccines to the digital tools that can be leveraged to track a crisis—with affordability and accessibility in mind.
This month’s PATH Insights is examining vaccine equity from all angles—from clinical trials and risk assessments to systems infrastructure and safe immunization supplies—exploring what it takes to equitably vaccinate the world.
PATH’s team in India is working side by side with state governments on the COVID-19 response—from procuring oxygen concentrators to supporting greater infrastructure for coronavirus testing.
This month, Nikolaj Gilbert advocates for equitable access to medical oxygen; Neha Agarwal and colleagues unveil new variant-specific diagnostic dashboards for health officials; Cathy Ndiaye explains how countries are preparing for mass vaccination; Miren Iturriza-Gomara shares lessons from rotavirus for SARS-CoV-2; and Rachana Parikh and Bhushan Girase highlight the pandemic’s impact on mental health in India.
In honor of International Women's Day, these stories celebrate women who have dedicated their careers to public health, and exemplify the leadership and lived experience it takes to move humanity forward.
When will we reach herd immunity? Will mRNA vaccines influence vaccine manufacturing? How can the Biden-Harris administration support global public health? Can digital tools decentralize contact tracing?
Our articles this month reflect our values—from translating ambitious meningitis proposals into impact and success, to applying innovative technology to control tuberculosis, to speaking out against the hatred and violence that produces many of the inequities we work to address.